Structured evidence table for Lactobacillus Plantarum Exercise Recovery Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lactobacillus Plantarum Exercise Recovery Randomized Trial | Effect of Lactiplantibacillus plantarum GKK1 Supplementation on Exercise-Induced Fatigue, Muscle Damage, and Recovery in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled Trial | 2 | Lee M (2026) | Effect of Lactiplantibacillus plantarum GKK1 Supplementation on Exercise-Induced Fatigue, Muscle Damage, and Recovery in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Lactobacillus Plantarum Exercise Recovery Randomized Trial | 9 11 12 13 14 15 16 Prevotella Faecalibacterium Eubacterium Studies have shown that muscle mass and strength are strongly associated with the composition of GM (–). | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
| Lactobacillus Plantarum Exercise Recovery Randomized Trial | For instance, recent systematic reviews have reported a significant association between reduced GM diversity and the occurrence of sarcopenia, and the reduction of some specific bacteria, such asandmight be associated with muscle loss (,). | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
| Lactobacillus Plantarum Exercise Recovery Randomized Trial | Moreover, in patients with chronic diseases such as heart failure and chronic kidney disease, changes in the GM are also closely associated with sarcopenia, which further supporting the concept of the gut-muscle axis (,). | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
| Lactobacillus Plantarum Exercise Recovery Randomized Trial | 1 2 3 Sarcopenia is an age-related condition characterized by generalized loss of skeletal muscle mass, strength, and physical function, which has a negative impact on the life quality and health status of elderly individuals. | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
Source documents